(Q78222516)
Statements
Treatment of primary Sjögren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group (English)
Ship JA
Fox PC
Michalek JE
Cummins MJ